PERASO INC (PRSO)

US71360T2006 - Common Stock

0.8651  +0.01 (+1.37%)

After market: 0.8501 -0.02 (-1.73%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to PRSO. PRSO was compared to 108 industry peers in the Semiconductors & Semiconductor Equipment industry. While PRSO seems to be doing ok healthwise, there are quite some concerns on its profitability. While showing a medium growth rate, PRSO is valued expensive at the moment.



0

1. Profitability

1.1 Basic Checks

In the past year PRSO has reported negative net income.
In the past year PRSO has reported a negative cash flow from operations.
In the past 5 years PRSO always reported negative net income.
PRSO had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

PRSO has a Return On Assets of -251.65%. This is amonst the worse of the industry: PRSO underperforms 98.15% of its industry peers.
PRSO's Return On Equity of -893.68% is on the low side compared to the rest of the industry. PRSO is outperformed by 94.44% of its industry peers.
Industry RankSector Rank
ROA -251.65%
ROE -893.68%
ROIC N/A
ROA(3y)-107.86%
ROA(5y)-80.26%
ROE(3y)-216.54%
ROE(5y)-169.05%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Looking at the Gross Margin, with a value of 21.73%, PRSO is doing worse than 75.93% of the companies in the same industry.
In the last couple of years the Gross Margin of PRSO has declined.
The Profit Margin and Operating Margin are not available for PRSO so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 21.73%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-40.83%
GM growth 5Y-26.1%

4

2. Health

2.1 Basic Checks

PRSO does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for PRSO has been increased compared to 1 year ago.
The number of shares outstanding for PRSO has been increased compared to 5 years ago.
There is no outstanding debt for PRSO. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

PRSO has an Altman-Z score of -39.75. This is a bad value and indicates that PRSO is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of -39.75, PRSO is not doing good in the industry: 86.11% of the companies in the same industry are doing better.
PRSO has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -39.75
ROIC/WACCN/A
WACC15.53%

2.3 Liquidity

A Current Ratio of 1.08 indicates that PRSO should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.08, PRSO is doing worse than 87.96% of the companies in the same industry.
PRSO has a Quick Ratio of 1.08. This is a bad value and indicates that PRSO is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of PRSO (0.56) is worse than 90.74% of its industry peers.
Industry RankSector Rank
Current Ratio 1.08
Quick Ratio 0.56

4

3. Growth

3.1 Past

PRSO shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 30.46%, which is quite impressive.
Looking at the last year, PRSO shows a very negative growth in Revenue. The Revenue has decreased by -19.46% in the last year.
Measured over the past years, PRSO shows a decrease in Revenue. The Revenue has been decreasing by -3.70% on average per year.
EPS 1Y (TTM)30.46%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%78.75%
Revenue 1Y (TTM)-19.46%
Revenue growth 3Y26.48%
Revenue growth 5Y-3.7%
Sales Q2Q%-14.28%

3.2 Future

PRSO is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 24.38% yearly.
The Revenue is expected to grow by 8.74% on average over the next years. This is quite good.
EPS Next Y87.83%
EPS Next 2Y38.27%
EPS Next 3Y24.38%
EPS Next 5YN/A
Revenue Next Year16.37%
Revenue Next 2Y3.14%
Revenue Next 3Y8.74%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for PRSO. In the last year negative earnings were reported.
Also next year PRSO is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

A more expensive valuation may be justified as PRSO's earnings are expected to grow with 24.38% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y38.27%
EPS Next 3Y24.38%

0

5. Dividend

5.1 Amount

No dividends for PRSO!.
Industry RankSector Rank
Dividend Yield N/A

PERASO INC

NASDAQ:PRSO (12/20/2024, 8:00:01 PM)

After market: 0.8501 -0.02 (-1.73%)

0.8651

+0.01 (+1.37%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)11-12 2024-11-12/amc
Earnings (Next)N/A N/A
Inst Owners2.14%
Inst Owner Change95.14%
Ins Owners3.3%
Ins Owner Change-0.89%
Market Cap3.30M
Analysts85
Price Target3.52 (306.89%)
Short Float %4.17%
Short Ratio0.75
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-89.11%
Min EPS beat(2)-136.37%
Max EPS beat(2)-41.84%
EPS beat(4)1
Avg EPS beat(4)-65.44%
Min EPS beat(4)-136.37%
Max EPS beat(4)38.59%
EPS beat(8)4
Avg EPS beat(8)-23.5%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-4.47%
Min Revenue beat(2)-6.79%
Max Revenue beat(2)-2.14%
Revenue beat(4)2
Avg Revenue beat(4)-0.79%
Min Revenue beat(4)-6.79%
Max Revenue beat(4)5.65%
Revenue beat(8)4
Avg Revenue beat(8)0.22%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-8%
PT rev (3m)-8%
EPS NQ rev (1m)56.96%
EPS NQ rev (3m)56.96%
EPS NY rev (1m)0%
EPS NY rev (3m)-60.73%
Revenue NQ rev (1m)-8.04%
Revenue NQ rev (3m)-8.04%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-7.8%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.26
P/FCF N/A
P/OCF N/A
P/B 1.63
P/tB 2.76
EV/EBITDA N/A
EPS(TTM)-10.57
EYN/A
EPS(NY)-1.63
Fwd EYN/A
FCF(TTM)-0.77
FCFYN/A
OCF(TTM)-0.77
OCFYN/A
SpS3.33
BVpS0.53
TBVpS0.31
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -251.65%
ROE -893.68%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 21.73%
FCFM N/A
ROA(3y)-107.86%
ROA(5y)-80.26%
ROE(3y)-216.54%
ROE(5y)-169.05%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-40.83%
GM growth 5Y-26.1%
F-Score3
Asset Turnover1.77
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 0.02%
Cap/Sales 0.01%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.08
Quick Ratio 0.56
Altman-Z -39.75
F-Score3
WACC15.53%
ROIC/WACCN/A
Cap/Depr(3y)18.87%
Cap/Depr(5y)32.39%
Cap/Sales(3y)3.88%
Cap/Sales(5y)2.74%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)30.46%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%78.75%
EPS Next Y87.83%
EPS Next 2Y38.27%
EPS Next 3Y24.38%
EPS Next 5YN/A
Revenue 1Y (TTM)-19.46%
Revenue growth 3Y26.48%
Revenue growth 5Y-3.7%
Sales Q2Q%-14.28%
Revenue Next Year16.37%
Revenue Next 2Y3.14%
Revenue Next 3Y8.74%
Revenue Next 5YN/A
EBIT growth 1Y2.21%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year57.58%
EBIT Next 3Y32.11%
EBIT Next 5YN/A
FCF growth 1Y84.49%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y83.92%
OCF growth 3YN/A
OCF growth 5YN/A